26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Broschiertes Buch

This book hopes to provide an overview of the European Union insurance legislative background. In the first place, it shows the reasons why Solvency II is going to be introduced, following with an overall view of Solvency II legislative implementing process, composition and capital requirements. Lastly it shows the requirements for undertakings' corporate governance and focusing on the assessment of the market risk module of regulation's standard formula. Data for this research were obtained mainly from regulators internet address, as the main resource for all insurance undertakings regulated…mehr

Produktbeschreibung
This book hopes to provide an overview of the European Union insurance legislative background. In the first place, it shows the reasons why Solvency II is going to be introduced, following with an overall view of Solvency II legislative implementing process, composition and capital requirements. Lastly it shows the requirements for undertakings' corporate governance and focusing on the assessment of the market risk module of regulation's standard formula. Data for this research were obtained mainly from regulators internet address, as the main resource for all insurance undertakings regulated by EIOPA. On the basis of what has been elaborated in this research, it can be concluded that the risk-based approach introduced by the Solvency II Directive is a good measure for improving the insurer's market performance and control together with increasing the safety of the policyholder.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Marsida Stafa was born in Albania in 1986. She graduated in Quantitative Finance and Insurance at the University of Turin, Italy. During her studies, she attained knowledge in both finance and insurance fields. With a strong motivation in becoming a future actuary, she decided to make part of her research the upcoming European Directive SolvencyII.